Cargando…
Prevention of Arthritis by Locally Synthesized Recombinant Antibody Neutralizing Complement Component C5
Treatment of patients suffering from chronic diseases such as rheumatoid arthritis with recombinant antibodies is time consuming and fairly expensive and can be associated with side effects due to generalized depletion of the target molecule. We have addressed these issues by developing an alternati...
Autores principales: | Durigutto, Paolo, Macor, Paolo, Ziller, Federica, De Maso, Luca, Fischetti, Fabio, Marzari, Roberto, Sblattero, Daniele, Tedesco, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591401/ https://www.ncbi.nlm.nih.gov/pubmed/23505550 http://dx.doi.org/10.1371/journal.pone.0058696 |
Ejemplares similares
-
Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage
por: Durigutto, Paolo, et al.
Publicado: (2017) -
Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients
por: Macor, Paolo, et al.
Publicado: (2021) -
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma
por: Busato, Davide, et al.
Publicado: (2023) -
Complement as a Biological Tool to Control Tumor Growth
por: Macor, Paolo, et al.
Publicado: (2018) -
Invasive meningococcal disease in three siblings with hereditary deficiency of the 8(th) component of complement: evidence for the importance of an early diagnosis
por: Dellepiane, Rosa Maria, et al.
Publicado: (2016)